Search Results - "Shaughnessy, Rita"

Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome by Harner, Matthew K., Lichtenstein, Maya, Farrell, Martilias, Dietterich, Tyler E., Filmyer, Dawn M., Bruno, Lisa M., Biondi, Tamara F., Crowley, James J., Lázaro-Muñoz, Gabriel, Stowe, Robert, Shaughnessy, Rita A., Berg, Jonathan S., Szatkiewicz, Jin, Sullivan, Patrick F., Josiassen, Richard C.

“…The 3q29 deletion is a rare copy number variant associated with neurodevelopmental and psychiatric disorders, including a >40-fold increased risk for…”
Get full text

A comparison of simple reaction times in psychotic inpatients with and without hyponatremia by Filmyer, Dawn M., Finkel, Genna, Plasay, Michael, Shaughnessy, Rita A., Josiassen, Richard C.

Get full text

Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant Psychosis by Farrell, Martilias, Dietterich, Tyler E, Harner, Matthew K, Bruno, Lisa M, Filmyer, Dawn M, Shaughnessy, Rita A, Lichtenstein, Maya L, Britt, Allison M, Biondi, Tamara F, Crowley, James J, Lázaro-Muñoz, Gabriel, Forsingdal, Annika E, Nielsen, Jacob, Didriksen, Michael, Berg, Jonathan S, Wen, Jia, Szatkiewicz, Jin, Mary Xavier, Rose, Sullivan, Patrick F, Josiassen, Richard C

“…Abstract Background It remains unknown why ~30% of patients with psychotic disorders fail to respond to treatment. Previous genomic investigations of…”
Get full text

Clozapine Augmented With Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial by Josiassen, Richard C., Joseph, Ashok, Kohegyi, Eva, Stokes, Sudhir, Dadvand, Mahmood, Paing, Wynn Wynn, Shaughnessy, Rita A.

“…OBJECTIVE: The authors evaluated the efficacy and safety of augmenting clozapine with risperidone in patients with treatment-resistant schizophrenia. METHOD:…”
Get full text

Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington’s Disease by Farrell, Martilias, Lichtenstein, Maya, Crowley, James J, Filmyer, Dawn M, Lázaro-Muñoz, Gabriel, Shaughnessy, Rita A, Mackenzie, Ian R, Hirsch-Reinshagen, Veronica, Stowe, Robert, Evans, James P, Berg, Jonathan S, Szatkiewicz, Jin, Josiassen, Richard C, Sullivan, Patrick F

“…Farrell et al. presents a clinical case of developmental delay, treatment-resistant psychosis, and early-onset dementia in a 41-year-old man with 22q11…”
Get full text

Double-Blind, Placebo-Controlled, Multicenter Trial of a Vasopressin V2 -Receptor Antagonist in Patients with Schizophrenia and Hyponatremia by Josiassen, Richard C, Goldman, Morris, Jessani, Meera, Shaughnessy, Rita A, Albazzaz, Ala, Lee, Jennifer, Ouyang, John, Orlandi, Cesare, Czerwiec, Frank

“…Objectives Hyponatremia (serum sodium [Na+ ] concentration <136 mmol/L) is a prevalent and potentially life-threatening medical comorbidity for schizophrenic…”
Get full text

Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature by Farrell, Martilias, Lichtenstein, Maya, Harner, Matthew K., Crowley, James J., Filmyer, Dawn M., Lázaro-Muñoz, Gabriel, Dietterich, Tyler E., Bruno, Lisa M., Shaughnessy, Rita A., Biondi, Tamara F., Burkholder, Stephan, Donmoyer, Jane, Berg, Jonathan S., Szatkiewicz, Jin, Sullivan, Patrick F., Josiassen, Richard C.

“…The 15q11.2 BP1-BP2 (Burnside-Butler) deletion is a rare copy number variant impacting four genes ( NIPA1, NIPA2, CYFIP1, and TUBGCP5 ), and carries increased…”
Get full text

Reconsidering Chronic Hyponatremia in Psychosis by JOSIASSEN, Richard C, FILMYER, Dawn M, GEBOY, Alexander G, SHAUGHNESSY, Rita A

Get full text

Successful Treatment of Severe Tardive Dyskinesia with Valbenazine, Including a Patient's Perspective by Josiassen, Richard C, Filmyer, Dawn M, Gillean, Jack, Shah, Syed Sikandar, Dietterich, Tyler E, Shaughnessy, Rita A

“…BACKGROUND Tardive dyskinesia (TD) is a chronic involuntary movement disorder frequently induced by dopamine receptor blockers, particularly first-generation…”
Get full text

Impact of hyponatremia on resource utilization in state psychiatric hospitals: a retrospective analysis by Josiassen, Richard C, Filmyer, Dawn M, Geboy, Alexander G, Martin, Danielle, Curtis, Jessica L, Shaughnessy, Rita A

Get full text

Attributing Hyponatraemia to Treatment with Antipsychotic Medications by Josiassen, Richard C., Shaughnessy, Rita A., Filmyer, Dawn M., Audino, Brett

Get full text

Psychomotor Deficits Associated With Hyponatremia: A Retrospective Analysis by Josiassen, Richard C., Filmyer, Dawn M., Geboy, Alexander G., Martin, Danielle M., Curtis, Jessica L., Shaughnessy, Rita A., Salzman, Amber, Orlandi, Cesare

“…Hyponatremia (serum sodium concentration [Na+] < 136 mEq/L) is a potentially life-threatening condition. Recent evidence (Renneboog, Musch, Vandemergel, Manto,…”
Get full text

Continuing professional development and social accountability: A review of the literature by Fleet, Lisa J., Kirby, Fran, Cutler, Sarah, Dunikowski, Lynn, Nasmith, Louise, Shaughnessy, Rita

“…The idea that health professionals should be accountable to the society they serve is not a new concept and by the 1990s, the continuing professional…”
Get full text

DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF A VASOPRESSIN V2-RECEPTOR ANTAGONIST IN PATIENTS WITH SCHIZOPHRENIA AND HYPONATREMIA by Josiassen, Richard, Goldman, Morris, Jessani, Meera, Shaughnessy, Rita A, Czerwick, Frank, Orlandi, Cesare

Get full text

Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders by Josiassen, Richard C, Curtis, Jessica, Filmyer, Dawn M, Audino, Brett, Skuban, Nina, Shaughnessy, Rita A

“…Hyponatremia (serum sodium concentration < 136 mEq/liter) is a common and potentially life-threatening medical comorbidity seen in patients with psychotic…”
Get more information

Vaptans are effective in treating hyponatremia in psychotic patients: but we need treatment guidelines by Josiassen, Richard C, Filmyer, Dawn M, Gillean, John A, Shaughnessy, Rita A

Get full text

Vaptans: a potential new approach for treating chronic hyponatremia in psychotic patients by Josiassen, Richard C, Curtis, Jessica L, Shaughnessy, Rita A, Filmyer, Dawn M, Geboy, Alexander G, Skuban, Nina, Ouyang, John, Czerwiec, Frank

“…Hyponatremia (serum sodium concentration [Na+] <136 mEq/L) is a potentially life-threatening condition often found chronically in patients with psychotic…”
Get more information

Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study by Josiassen, Richard C., Shaughnessy, Rita A., Filymer, Dawn M., Donohue, Ann Marie, Kacso, Margit, Finkel, Naomi, Curtis, Jessica, Audino, Brett, Skuban, Nina

“…Objective: The objective was to compare short‐term effectiveness of aripiprazole with three other second‐generation antipsychotics (SGAs) in the treatment of…”
Get full text

T98. CHALLENGES AND ETHICAL CONSIDERATIONS IN RECRUITING PATIENTS WITH ``EXTREME'' TREATMENT-RESISTANT SCHIZOPHRENIA FOR GENOMIC INVESTIGATIONS: THE PASH STUDY by Xavier, Rose Mary, Dietterich, Tyler, Harner, Matthew, Filmyer, Dawn, Bruno, Lisa, Lichtenstein, Maya, Lazaro-Munoz, Gabriel, Farrell, Martilias, Shaughnessy, Rita, Sullivan, Patrick, Josiassen, Richard

“…Many patients (∼30%) with schizophrenia experience little or no benefit from antipsychotic medications (“treatment-resistant schizophrenia” - TRS). Extreme…”
Get full text

SA46. Comparison of Simple Reaction Times in Psychotic Inpatients With and Without Hyponatremia by Filmyer, Dawn, Finkel, Genna, Shaughnessy, Rita, Josiassen, Richard

“…Background: Hyponatremia (HN; serum sodium concentration [Na+] < 136 mEq/L) is a prevalent and potentially life-threatening condition often seen in psychotic…”
Get full text